RE:YOUTH (YONSEI BH Arterial Stemcell Clinic)
Сіз Bookimed қызметтері үшін төлемейсіз. жүрек талмасынан кейінгі асқынулардың емдеудің бағалары клиниканың баға тізіміне сәйкес келеді. Сіз жеткенде тікелей клиникада төлейсіз. Бөліктермен төлеу қолжетімді.
Bookimed Сіздің қауіпсіздігіңізді қамтамасыз етеді. Біз тек жүрек талмасынан кейінгі асқынулардың жүргізу үшін жоғары халықаралық стандарттарға сәйкес келетін клиникалармен ғана жұмыс істейміз. Олардың бүкіл әлем бойынша халықаралық науқастарға қызмет көрсету үшін қажетті лицензиялары бар.
Bookimed тегін көмек және қолдау ұсынады. Жеке медициналық координатор сапарға дейін, кезінде және кейін Сізбен байланыста. жүрек талмасынан кейінгі асқынулардың емдеу кезінде Сіз басқа елде жалғыз қалмайсыз.
Dr. Oh Dong Joo is a cardiologist. He specializes in coronary artery disease, valvular heart disease, heart failure, hypertension, and atrial fibrillation.
MD and PhD, Korea University. Professor of Cardiology, Korea University. Cardiology Fellow, Emory University. Clinical Instructor, Cornell University.
Leadership: Chairman, Korean Society of Cardiology. President, Korean Society of Interventional Cardiology. President, Korean Chapter of the ACC. Director, Cardiovascular Research Institute, Korea University.
Publications: 386 total. 242 SCI-indexed international papers.
Dr. Kyung-Hee Kim, MD, PhD, is Director of the Heart Transplantation Center and Head of Cardiology at Incheon Sejong Hospital. She earned her MD, MS, and PhD at Seoul National University College of Medicine. She completed international fellowships, including research at the Mayo Clinic.
Her expertise includes advanced heart failure, transplant evaluation and management, mechanical circulatory support (VAD, ECMO), pulmonary hypertension, complex cardiomyopathies, and genetic, valvular, and adult congenital heart disease.
She leads multidisciplinary cardiac care. She develops clinical protocols and education programs and contributes to research and guideline development in pulmonary hypertension and heart failure. She serves on the AHA Clinical Cardiology Membership Committee.
Dr. Min-Jeong Kim, MD, PhD, is a cardiologist at Incheon Sejong Hospital. She focuses on interventional cardiology, heart failure, hypertension, and preventive cardiology.
She earned her MD and PhD from Seoul National University College of Medicine. She completed advanced training in internal medicine and cardiovascular disease at a major medical center in Korea.
Her expertise includes coronary artery disease, chronic heart failure, arrhythmias, and hypertension. She performs coronary angiography and percutaneous coronary intervention. She is skilled in diagnostic echocardiography and comprehensive cardiovascular evaluation.
She provides evidence-based care with careful risk assessment and personalized treatment. She works with multidisciplinary cardiac teams to improve prevention and long-term outcomes.
Professor Byung-Hee Oh, MD, PhD, is a cardiologist at Incheon Sejong Hospital. He graduated from Seoul National University College of Medicine. He completed training in Internal Medicine and Cardiology at Seoul National University Hospital. His clinical focus includes heart failure, coronary artery disease, hypertension, atrial fibrillation, and preventive cardiology.
He served as Professor of Cardiology at Seoul National University. He also served as Director of a cardiovascular center and Head of the Division of Cardiology. He was President of the Korean Society of Cardiology and led national heart failure and hypertension groups. He has authored hundreds of peer-reviewed publications. He has given invited lectures at major international cardiology conferences and received national honors.
Korean hospitals treat post-MI complications using rapid revascularization within 12 hours. Specialist teams utilize Mechanical Circulatory Support like ECMO or ventricular assist devices for heart failure. Advanced protocols include dual antiplatelet therapy and drug-eluting stents. High-volume centers often hold Korea Institute for Healthcare Accreditation (KOIHA) certification.
Bookimed Expert Insight: While most centers focus on traditional recovery, RE:YOUTH clinic provides arterial stem cell therapy for chronic tissue repair. This regenerative approach is rare globally. The clinic limits intake to 2 patients daily. This ensures VIP-level attention for complex post-MI recovery cases in Cheonan.
Standard long-term medication after a heart attack in Korea includes statins, antiplatelets, and RAS inhibitors. Dual antiplatelet therapy often lasts 6 to 12 months before transitioning to single agents. Patients with heart failure or low ejection fractions typically receive ACE inhibitors or ARBs for cardiac protection.
Bookimed Expert Insight: Korean cardiology leaders like Dr. Oh Dong Joo at Na-Eun Hospital and Dr. Byung Hee Oh at Sejong Hospital specialize in complex post-infarction care. Data shows these top-tier specialists focus on evidence-based risk stratification. This ensures patients do not stay on beta-blockers longer than necessary if their heart function stabilizes.
Patient Consensus: Patients note that dual antiplatelet therapy often lasts much longer than they initially expected. They emphasize the importance of never stopping these medications suddenly, especially after receiving a stent.
Heart failure treatments in Korea prioritize Guideline-Directed Medical Therapy (GDMT) including ARNI and SGLT2 inhibitors. Advanced cases utilize ventricular assist devices (VAD) and heart transplantation. Specialist centers like Sejong Hospital offer regenerative options such as arterial stem cell infusion alongside standard interventional cardiology protocols.
Bookimed Expert Insight: Korea stands out globally by combining standard cardiac care with niche regenerative medicine. While Sejong Hospital focuses on high-volume transplantation, RE:YOUTH clinic accepts only 2 patients daily for personalized stem cell therapy. This allows patients to choose between massive academic centers or boutique clinics for post-MI recovery.
South Korea provides dedicated English-language cardiac care through specialized international healthcare centers in major hospital networks. Institutions like Sejong Hospital and Na-Eun Hospital employ specialists with fellowship training from Mayo Clinic and Emory University to manage complex post-myocardial infarction complications for international patients.
Bookimed Expert Insight: Patients seeking post-MI care should prioritize tertiary centers like Sejong Hospital over smaller clinics. These facilities integrate interventional cardiology with cardiac rehabilitation and ICU support. Our data shows top Korean cardiologists often hold dual PhDs and US fellowships, offering technical skills comparable to leading Western institutions.
Patient Consensus: Patients trust the technical medical quality in Korea but note that communication in wards can be limited. They recommend using professional coordination to handle consent forms and discharge instructions during recovery.
Cardiac rehabilitation in Korea is a specialist-led program focusing on secondary prevention through medication adherence and monitored physical activity. Multi-disciplinary teams at JCI-accredited centers like Sejong Hospital use ECG-monitored exercise to safely restore heart function. Programs combine clinical oversight by cardiologists with nutrition and stress counseling for recovery.
Bookimed Expert Insight: While many programs are hospital-based, Korea's top specialists like Dr. Oh Dong Joo at Na-Eun Hospital bring academic rigor from Emory and Cornell. Our data shows patients prioritize centers where the Cardiology Head also leads research institutes. This integration ensures patients receive rehabilitation protocols based on the latest global clinical trials and SCI-indexed recovery data.
Patient Consensus: Patients note that recovery feels very doctor-led, with a heavy emphasis on medication schedules and family-supported lifestyle changes. Many observe that while big hospitals provide excellent initial guidance, patients often feel pressure to resume work quickly due to local culture.